Difference between revisions of "Pharm Tech Agenda 2011.11.10"
Jump to navigation
Jump to search
m (Created page with "== Topics to be discussed == === Questions === * ? * ? === ? === === ? ===") |
|||
Line 1: | Line 1: | ||
== Topics to be discussed == | == Topics to be discussed == | ||
+ | |||
+ | === current state of the medication Documentation white paper (Marco, Ana)=== | ||
=== Questions === | === Questions === | ||
− | * | + | * existing use cases - do we have enough compelling use cases ? (Marco, Tom) |
+ | |||
+ | * Comparison to PCC QED and to PCC RECON (Marco) | ||
+ | |||
+ | * '''Decision''' on | ||
+ | |||
+ | :: *how to proceed, | ||
+ | |||
+ | ::* distribution of workload, | ||
+ | |||
+ | ::* timetable, | ||
+ | |||
+ | ::* is it going to be a CP? | ||
+ | |||
+ | ::::* If yes, a CP to what profile, PCC Medication Reconciliation? | ||
+ | |||
+ | * Variations ? | ||
− | |||
− | |||
=== ? === | === ? === |
Revision as of 05:15, 3 November 2011
Topics to be discussed
current state of the medication Documentation white paper (Marco, Ana)
Questions
- existing use cases - do we have enough compelling use cases ? (Marco, Tom)
- Comparison to PCC QED and to PCC RECON (Marco)
- Decision on
- *how to proceed,
- distribution of workload,
- timetable,
- is it going to be a CP?
- If yes, a CP to what profile, PCC Medication Reconciliation?
- Variations ?